People · Operator
Named in public records as an officer, director or promoter · active 2012–2012 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Flex Biomedical, Inc. | — | Pharmaceuticals | Pre-Seed | $2.4M | $41.7M | 2012 |
Mark P. Grinstaff at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark P. Grinstaff on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David C. Sneider | 1 | 2 |
| Hideki C. Suzuki, PhD | 1 | 1 |
| Nicholas E. Mischler, MD | 1 | 1 |
| Salvatore P. Braico | 1 | 1 |
| Steven R. Pollock, RPh, MBA | 1 | 1 |
| Michael C. Wathier, PhD | 1 | 1 |
| Donald R. Urbanowicz | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.